Hydropathic analysis of the free energy differences in anthracycline antibiotic binding to DNA

Nucleic Acids Research

Volumn 31, Issue 15, 2003, Pages 4410-4416

  Cashman, Derek J ^a   Scarsdale, J Neel ^a   Kellogg, Glen E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRIAMYCINONE; AMINE; ANTHRACYCLINE ANTIBIOTIC AGENT; CARBENE; DAUNOMYCINONE; DAUNORUBICIN; DAUNOSAMINE; DNA; DOXORUBICIN; DOXORUBICIN DERIVATIVE; HYDROXYL GROUP; OXYGEN; ANTINEOPLASTIC ANTIBIOTIC; DRUG DERIVATIVE;

ARTICLE; CALCULATION; CONTROLLED STUDY; DNA SEQUENCE; DRUG CONFORMATION; DRUG DNA BINDING; DRUG STRUCTURE; HYDROPHOBICITY; METHODOLOGY; PRIORITY JOURNAL; PROTON TRANSPORT; SCORING SYSTEM; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; BASE PAIRING; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; NUCLEOTIDE SEQUENCE;

ANTIBIOTICS, ANTINEOPLASTIC; BASE PAIRING; BASE SEQUENCE; BINDING SITES; DNA; DOXORUBICIN; MODELS, MOLECULAR;

EID: 0043163784     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg645     Document Type: Article

References (26)

1. Weiss, R.B. (1992) The anthracyclines: will we ever find a better doxorubicin? Semin. Oncol., 19, 670-686.
2. Momparler, R.L., Karon, M., Siegel, S.E. and Avila, F. (1976) Effect of adriamycin on DNA, RNA and protein synthesis in cell-free systems and intact cells. Cancer Res., 36, 2891-2895.
3. Tewey, K.M., Rowe ,T.C., Yang, L., Halligan, B.D. and Lui, L.F. (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science, 226, 466-468.
4. Schneider, E., Hsiang, Y. and Lui ,L.F. (1990) DNA topoisomerases as anticancer drug targets. Adv. Pharmacol., 21, 149-183.
5. Sander ,M. and Tsieh, T.-S. (1983) Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster. J. Biol. Chem., 258, 8421-8428.
6. Chaires, J.B., Priebe, W., Graves, D.E. and Burke, T.G. (1993) Dissection of the free energy of anthracycline antibiotic binding to DNA: electrostatic contributions. J. Am. Chem. Soc., 115, 5360-5364.
7. Chaires, J.B. (1990) Daunomycin binding to DNA: from the macroscopic to the microscopic. In Pullman,B. and Jortner,J. (eds), Molecular Basis of Specificity in Nucleic Acid-Drug Interactions. Kluwer Academic, Dordrecht, The Netherlands, pp. 123-136.
8. Chen, K.-X., Gresh, N. and Pullman, B.A. (1986) Theoretical investigation on the sequence selective binding of adriamycin to double-stranded polynucleotides. Nucleic Acids Res., 14, 2251-2267.
9. Trist, H. and Phillips, D.R. (1989) In vitro transcription analysis of the role of flanking sequence on the DNA sequence specificity of adriamycin. Nucleic Acids Res., 17, 3673-3688.
10. Medhi, C., Mitchell, J.B.O., Price, S.L. and Tabor, A.B. (1999) Electrostatic factors in DNA intercalation. Biopolymers, 52, 84-93.
11. Fritzsche, H. and Watler, A. (1990) Physico-chemical studies on anthracycline-DNA interactions: analysis of equilibrium, kinetic and structural data. In Kallenbach,N.R. (ed.), Chemistry and Physics of DNA-Ligand Interactions. Adenine Press, Schenectady, NY, pp. 1-35.
12. Pullman, B. (1989) Molecular mechanisms of specificity in DNA-antitumour drug interactions. Adv. Drug Res., 18, 1-113.
13. Pullman, B. (1991) Sequence specificity in the binding of anti-tumour anthracyclines to DNA: a success of theory. Anticancer Drug Des., 6, 95-105.
14. Gao, Y.G., Priebe, W. and Wang, A.H.J. (1996) Substitutions at C2′ of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity. Eur. J. Biochem., 240, 331-335.
15. Kellogg, G.E., Scarsdale, J.N. and Fornari, F.A. (1998) Identification and hydropathic characterization of structural features affecting sequence specificity for doxorubicin intercalation into DNA double-stranded polynucleotides. Nucleic Acids Res., 26, 4721-4732.
16. Chaires, J.B., Satyanarayana, S., Suh, D., Fokt, I., Przewloka, T. and Priebe, W. (1996) Parsing the free energy of anthracycline antibiotic binding to DNA. Biochemistry, 35, 2047-2053.
17. Burnett, J.C., Kellogg, G.E. and Abraham, D.J. (2000) Computational methodology for estimating changes in free energies of biomolecular association upon mutation. The importance of bound water in dimertetramer assembly for β-37 mutant hemoglobins., Biochemistry, 39, 1622-1633.
18. Cozzini, P., Fornabaio, M., Marabotti, A., Abraham, D.J., Kellogg, G.E. and Mozzarelli ,A. (2002) Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water. J. Med. Chem., 45, 2469-2483.
19. o/w more than the sum of its parts? Eur. J. Med. Chem., 35, 651-661.
20. Kellogg, G.E., Scarsdale, J.N. and Cashman, D.J. (1999) Ligand docking and scoring in DNA oligonucleotides. Binding of doxorubicin and modeled analogs to optimize sequence specificity. Med Chem. Res., 9, 592-603.
21. Abraham, D.J., Kellogg, G.E., Holt, J.M. and Ackers, G.K. (1997) Hydropathic analysis of the non-covalent interactions between molecular subunits of structurally characterized hemoglobins. J. Mol. Biol., 272, 613-632.
22. Frederick, C.A., Williams, L.D., Ughetto, G., van der Marel, G.A., van Boom, J.H., Rich ,A. and Wang, A.H.-J. (1990) Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Biochemistry, 29, 2538-2549.
23. Hansch, C. and Leo, A.J. (1979) Substituent Constants for Correlation Analysis in Chemistry and Biology. John Wiley & Sons, New York, NY.
24. Andrews, P.R., Craik, D.J. and Martin, J.L. (1984) Functional group contributions to drug-receptor interactions. J. Med. Chem., 27, 1648-1657.
25. Cocco ,L., Temple, C., Montgomery, J.A., London, R.E. and Blakley, R.L. (1981) Protonation of methotrexate bound to the catalytic site of dihydrofolate reductase from Lactobacillus casei. Biochem. Biophys. Res. Commun., 100, 413-419.
26. Speelmans ,G., Staffhorst, W.H.M., de Kruijff, B. and de Wolf, F.A. (1994) Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plasma membrane. Biochemistry, 33, 13761-13768.